Zheng Wenshuai, Chen Zhaoguang, Cai Yibo, Wu Zongze, Du Zhenlan, Li Xiaohong, Li Beicheng, Zhu Shibin, Ning Hongmei
Department of Hematology, Hainan Hospital of Chinese People's Liberation Army (PLA) General Hospital, Sanya, Hainan, China.
Hematology and Oncology Department of Pediatrics, The Seventh Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Front Immunol. 2025 Jul 2;16:1616541. doi: 10.3389/fimmu.2025.1616541. eCollection 2025.
Hemophagocytic lymphohistiocytosis can be classified as primary HLH (pHLH) and secondary HLH. The early identify of pHLH can facilitate successful treatment. The rapid screening test greatly facilitated the diagnostic process of pHLH. However, there are rare studies to explore the ability of sCD25 and cytotoxic T lymphocytes (CTLs) degranulation test to rapidly screen pHLH.
We validated the accuracies of sCD25 and CTLs degranulation test in screening pHLH in 1224 clinically confirmed or suspected HLH patients through calculating area under the curve (AUC) and diagnostic parameters at optimal threshold.
The sensitivities of sCD25 to identify pHLH with defects in cytotoxic pathway genes was 75.9%, with specificities of 57.3% and AUC of 0.640. The sensitivities of CTLs degranulation test to identify pHLH with defects in degranulation pathway genes was 87.0%, with specificities of 69.0% and AUC of 0.794. The sensitivities of combination of sCD25 and CTLs degranulation test to identify pHLH with defects in cytotoxic pathway genes was 90.0%, with specificities of 69.8% and AUC of 0.833.
For identifying pHLH, CTLs degranulation test is more sensitive and no less specific than sCD25 and the combination of sCD25 and CTLs degranulation test can improve the accuracy further.
噬血细胞性淋巴组织细胞增生症可分为原发性HLH(pHLH)和继发性HLH。pHLH的早期识别有助于成功治疗。快速筛查试验极大地促进了pHLH的诊断过程。然而,鲜有研究探讨可溶性CD25(sCD25)和细胞毒性T淋巴细胞(CTL)脱颗粒试验快速筛查pHLH的能力。
我们通过计算曲线下面积(AUC)和最佳阈值下的诊断参数,验证了sCD25和CTL脱颗粒试验在1224例临床确诊或疑似HLH患者中筛查pHLH的准确性。
sCD25识别细胞毒性通路基因缺陷型pHLH的敏感性为75.9%,特异性为57.3%,AUC为0.640。CTL脱颗粒试验识别脱颗粒通路基因缺陷型pHLH的敏感性为87.0%,特异性为69.0%,AUC为0.794。sCD25与CTL脱颗粒试验联合识别细胞毒性通路基因缺陷型pHLH的敏感性为90.0%,特异性为69.8%,AUC为0.833。
对于识别pHLH,CTL脱颗粒试验比sCD25更敏感且特异性不低,sCD25与CTL脱颗粒试验联合可进一步提高准确性。